I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Catenacci, D.V.T.
156
results:
Search for persons
X
Format
Online (155)
Print (1)
Mediatypes
E-Books (1)
Articles (Online) (87)
OpenAccess-fulltext (67)
Map (1)
Languages
english (143)
german (1)
more...
italian (1)
less...
Sorted by: Relevance
Sorted by: Year
?
1
Assessment of the impact of FcγRIIIA single-nucleotide poly..:
Serritella, A.V.
;
Grewal, N.K.S.
;
Peterson, B.
...
ESMO Gastrointestinal Oncology. 2 (2023) - p. 100012 , 2023
Link:
https://doi.org/10.1016/..
?
2
The clinical landscape of cell-free DNA alterations in 1671..:
Berchuck, J.E.
;
Facchinetti, F.
;
DiToro, D.F.
...
Annals of Oncology. 33 (2022) 12 - p. 1269-1283 , 2022
Link:
https://doi.org/10.1016/..
?
3
Margetuximab with retifanlimab as first-line therapy in HER..:
Catenacci, D.V.T.
;
Kang, Y.-K.
;
Yoon, H.H.
...
ESMO Open. 7 (2022) 5 - p. 100563 , 2022
Link:
https://doi.org/10.1016/..
?
4
Safety and efficacy of HER2 blockade by trastuzumab-based c..:
Catenacci, D.V.T.
;
Chung, H.C.
;
Shen, L.
...
ESMO Open. 7 (2022) 1 - p. 100360 , 2022
Link:
https://doi.org/10.1016/..
?
5
Trifluridine/tipiracil versus placebo for third or later li..:
Tabernero, J.
;
Shitara, K.
;
Zaanan, A.
...
ESMO Open. 6 (2021) 4 - p. 100200 , 2021
Link:
https://doi.org/10.1016/..
?
6
Quantitative proteomic analysis of HER2 expression in the s..:
An, E.
;
Ock, C.-Y.
;
Kim, T.-Y.
...
Annals of Oncology. 28 (2017) 1 - p. 110-115 , 2017
Link:
https://doi.org/10.1093/..
?
7
483 Development of a Quantitative Colorectal Cancer SRM Ass..:
Hembrough, T.
;
Henderson, L.
;
Xu, P.
...
European Journal of Cancer. 48 (2012) - p. 150 , 2012
Link:
https://doi.org/10.1016/..
?
8
Developing SHP2-based combination therapy for KRAS-amplifie..:
Li, Tianxia
;
Kikuchi, Osamu
;
Zhou, Jin
...
JCI Insight. 8 (2023) 3 - p. , 2023
Link:
https://doi.org/10.1172/..
?
9
Phase II Prospective, Open-Label Randomized Controlled Tria..:
Dhiman, Ankit
;
Vining, Charles C.
;
Witmer, Hunter D. D.
...
Annals of Surgical Oncology. 29 (2022) 7 - p. 4583-4592 , 2022
Link:
https://doi.org/10.1245/..
?
10
Correction: Phase II Study Evaluating 2 Dosing Schedules of..:
Shah, Manish A.
;
Wainberg, Zev A.
;
Catenacci, Daniel V. T.
...
PLOS ONE. 17 (2022) 10 - p. e0276211 , 2022
Link:
https://doi.org/10.1371/..
?
11
Epacadostat Plus Pembrolizumab and Chemotherapy for Advance..:
Powderly, John D
;
Klempner, Samuel J
;
Naing, Aung
...
The Oncologist. 27 (2022) 11 - p. 905-e848 , 2022
Link:
https://doi.org/10.1093/..
?
12
ASO Visual Abstract: Phase II Prospective Open-Label Random..:
Dhiman, Ankit
;
Vining, Charles C.
;
Witmer, Hunter D. D.
...
Annals of Surgical Oncology. 29 (2022) S3 - p. 616-617 , 2022
Link:
https://doi.org/10.1245/..
?
13
A pan-cancer organoid platform for precision medicine:
Larsen, Brian M.
;
Kannan, Madhavi
;
Langer, Lee F.
...
Cell Reports. 36 (2021) 4 - p. 109429 , 2021
Link:
https://doi.org/10.1016/..
?
14
Immune-Checkpoint Inhibition in the Treatment of Gastro-Eso..:
Paydary, Koosha
;
Reizine, Natalie
;
Catenacci, Daniel V. T.
Cancers. 13 (2021) 23 - p. 5929 , 2021
Link:
https://doi.org/10.3390/..
?
15
Correction: Phase II Study Evaluating 2 Dosing Schedules of..:
Shah, Manish A.
;
Wainberg, Zev A.
;
Catenacci, Daniel V. T.
...
PLOS ONE. 16 (2021) 12 - p. e0261994 , 2021
Link:
https://doi.org/10.1371/..
1-15
Related subjects
Geologische Karten -- Italien
Nachhaltiges Management